Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.8 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |